UK MHRA: COVID-19 To Spark Rise In Clinical Trial-Related Deviations

 
• By Vibha Sharma

The UK’s Medicines and Healthcare products Regulatory Agency says that any increase in clinical trial protocol deviations in relation to coronavirus outbreak will not constitute a serious breach.

Coronavirus
Coronavirus Is Challenging The Clinical Trial Environment • Source: Shutterstock

More from Clinical Trials

More from R&D